首頁 > 市場調查報告書 > 醫療設備

生技設備細胞培養

市場調查報告書

商品編碼

1111956

實驗動物模式，3D培養，類器官的全球市場

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

出版日期: 2022年08月10日 | 出版商:

BCC Research | 英文 198 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球類器官的市場規模，2022年成為14億美元。

該市場，預計在2022年～2027年的預測期間內以22.2％的年複合成長率擴大，2027年達到37億美元。

本報告提供全球類器官市場相關調查，市場概要，以及各內臟器官類型，各用途，各地區趨勢，及加入此市場的主要企業簡介等資訊。

動物模式企業
ALPHA GENESIS INC.
CHARLES RIVER LABORATORIES INTERNATIONAL INC.
ENVIGO
GENOWAY S.A.
LABCORP DRUG DEVELOPMENT (COVANCE INC.)
THE JACKSON LABORATORY
JANVIER LABS
OAK HILL GENETICS
PRIMGEN
TACONIC BIOSCIENCES
TRANSGENIC INC.
TRANSPOSAGEN BIOPHARMACEUTICALS INC.
生物印刷、再生醫療企業
ALLEVI
ASPECT BIOSYSTEMS LTD.
BIOINK SOLUTIONS INC.
CELLINK INC.
COLLPLANT HOLDINGS LTD.
EAST RIVER BIOSOLUTIONS/XYLYX BIO
EPIBONE
MATTEK CORP.
NANO 3D BIOSCIENCES INC.
ORGANOVO HOLDINGS INC.
PEPGEL LLC
REGENHU
TEVIDO BIODEVICES INC.
TISSUSE GMBH
Organ-on-Chip Companies
AXOSIM
EMULATE INC.
KIRKSTALL LTD.
MICRONIT MICROTECHNOLOGIES
MIMETAS
TARA BIOSYSTEMS INC.
類器官企業
3DNAMICS INC.
CELLESCE
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
CROWN BIOSCIENCE
CORNING INC.
DEFINIGEN
HUBRECHT ORGANOID TECHNOLOGY (HUB)
MERCK KGAA
R&D SYSTEMS INC.
STEMCELL TECHNOLOGIES INC.
THERMO FISHER SCIENTIFIC
TREVIGEN INC. (BIO-TECHNE)
其他的3D細胞培養企業
3D BIOTEK LLC
ADVANCED BIOMATRIX INC.
HORIZON DISCOVERY LTD.
INSPHERO INC.
PROMOCELL GMBH
REPROCELL INC.
SYNTHECON INC.

簡介目錄圖表

Product Code: PHM204B

Highlights:

The global market for organoids is estimated to increase from $1.4 billion in 2022 to reach $3.7 billion by 2027 with a compound annual growth rate (CAGR) of 22.2% from 2022 through 2027.

The global market for intestine organoids is estimated to increase from $320.3 million in 2022 to reach $885.2 million by 2027 with a CAGR of 22.5% from 2022 through 2027.

The global market for kidney organoids is estimated to increase from $118.6 million in 2022 to reach $336.0 million by 2027 with a CAGR of 23.2% from 2022 through 2027.

Report Scope:

The report describes three global markets: the animal models market, the 3D cultures market and the organoids market. The organoids market especially is described in more detail, with market estimation for different segments in a separate chapter of the report.

Report Includes:

26 data tables and 28 additional tables
An up-to-date review and analysis of the global markets for the laboratory animal models, 3D cell cultures, and organoids within the industry
Analyses of the global market trends, with historic market revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
Highlights of the current state of the industry structure, novel technological updates and issues surrounding integration of organoids and stringent regulatory constraints, ongoing research activities, and COVID-19 impact on the overall market
Estimation of the actual market size and market forecast for organoids in USD million values, and their corresponding market share analysis by product type, application, and geographic region
Regional and country specific data and analysis for organoids in the U.S., Canada, Germany, U.K., France, Italy, Spain, Japan, Australia, China and India etc.
Information on the current trends that significantly affect the basic research, biomedical and other industries where animals are used for toxicity testing and also for evaluating the safety and metabolism of chemical compounds
Analysis of market opportunities with a holistic review of advantages and disadvantages of the 3D cell cultures, animal models, and organoids in the prevailing biopharmaceuticals industry
Review of selected patents and patent applications on organoids, and emerging developments in the global market
Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
Descriptive company profiles of the leading Organoids market players, including Cellesce Ltd., Corning Inc., Merck KGaA, Thermo Fisher Scientific Inc., Hubrecht Organoid Technology (HUB), and STEMCELL Technologies Inc.

Chapter 1 Introduction

Background
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in This Update?
Information Sources and Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Animal Model Market Technology Background

Methods of Animal Model and 3D Cell Culture Modification
Physical and Chemical Mutations
Targeted Mutations
Other Technologies
Laboratory Animal Models
Market Definition
Animal Model Lines
Common Species of Laboratory Animals

Chapter 4 Impact of COVID-19 on the Global Market for Organoids

Overview
Impact of COVID-19 on Organoids
Conclusion

Chapter 5 Market Dynamics

Market Drivers
Increasing Emphasis on Developing Alternative Approaches to Animal Testing
Rising Demand for Tumor Modelling and Biobanking to Drive Market Growth
Increasing Adoption of the Organoid Technology for Wide Range of Applications
Market Restraints
Stringent Government Regulatory Setting in Research and Development of Cell Cultures and Stem Cells
Concerns Associated with the Integration of Organoids into Current Workflows
Market Opportunities
Increasing Applications of Organoids in Drug Development, Personalized Medicine and Transplantational Medicine

Chapter 6 3D Cell Technology Background

3D Cell Cultures
Spheroids
2D Cultures vs. 2.5D Cultures vs. 3D Cultures
Scaffold-Based and Scaffold-Free 3D Cell Cultures
Scaffold-Free 3D Cell Cultures
Scaffold-Based 3D Cell Cultures
Tissue Engineering and Bioprinting
3D Bioprinting Technology
Types of Bioprinting Methods
Microfluidic Organ-on-Chip Platforms
Types of Organ-on-Chip Devices

Chapter 7 Market Breakdown by Organ Type

Global Market for Organoids, by Organ Type
Intestine
Market Size and Forecast
Liver
Market Size and Forecast
Stomach
Market Size and Forecast
Pancreas
Market Size and Forecast
Lung (Pulmonary)
Market Size and Forecast
Kidney
Market Size and Forecast
Others
Cardiac Organoids
Cancer Organoids
Market Size and Forecast

Chapter 8 Market Breakdown by Application

Global Market for Organoids, by Application
Developmental Biology
Market Size and Forecast
Drug Discovery and Personalized Medicine
Market Size and Forecast
Regenerative Medicine
Market Size and Forecast
Pathology of Infectious Disease
Market Size and Forecast
Drug Toxicity and Efficacy Testing
Market Size and Forecast

Chapter 9 Market Breakdown by Region

Global Market for Organoids, by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
Australia
India
Rest of Asia-Pacific
Rest of the World
Market Size and Forecast

Chapter 10 Patent Review/New Developments

Chapter 11 Analysis of Market Opportunities

Market Opportunities: Animal Models
Market Opportunities: 3D Cell Culture Segment
Organs-on-Chip
Organoids
Bioprinting
Advantages and Disadvantages of 3D Cell Cultures and Animal Models
Animal Models
3D Cell Cultures in General
Organoids
Organs-on-Chip

Chapter 12 Competitive Landscape

Chapter 13 Profiles of Companies and Important Institutions

Animal Model Companies
ALPHA GENESIS INC.
CHARLES RIVER LABORATORIES INTERNATIONAL INC.
ENVIGO
GENOWAY S.A.
LABCORP DRUG DEVELOPMENT (COVANCE INC.)
THE JACKSON LABORATORY
JANVIER LABS
OAK HILL GENETICS
PRIMGEN
TACONIC BIOSCIENCES
TRANSGENIC INC.
TRANSPOSAGEN BIOPHARMACEUTICALS INC.
Bioprinting and Regenerative Medicine Companies
ALLEVI
ASPECT BIOSYSTEMS LTD.
BIOINK SOLUTIONS INC.
CELLINK INC.
COLLPLANT HOLDINGS LTD.
EAST RIVER BIOSOLUTIONS/XYLYX BIO
EPIBONE
MATTEK CORP.
NANO 3D BIOSCIENCES INC.
ORGANOVO HOLDINGS INC.
PEPGEL LLC
REGENHU
TEVIDO BIODEVICES INC.
TISSUSE GMBH
Organ-on-Chip Companies
AXOSIM
EMULATE INC.
KIRKSTALL LTD.
MICRONIT MICROTECHNOLOGIES
MIMETAS
TARA BIOSYSTEMS INC.
Organoid Companies
3DNAMICS INC.
CELLESCE
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
CROWN BIOSCIENCE
CORNING INC.
DEFINIGEN
HUBRECHT ORGANOID TECHNOLOGY (HUB)
MERCK KGAA
R&D SYSTEMS INC.
STEMCELL TECHNOLOGIES INC.
THERMO FISHER SCIENTIFIC
TREVIGEN INC. (BIO-TECHNE)
Other 3D Cell Culture Companies
3D BIOTEK LLC
ADVANCED BIOMATRIX INC.
HORIZON DISCOVERY LTD.
INSPHERO INC.
PROMOCELL GMBH
REPROCELL INC.
SYNTHECON INC.

簡介目錄圖表

List of Tables

Summary Table : Global Market for Organoids, by Organ Type, Through 2027

Table A : Comparison of Changes in the Segmentation of the Old and New Version of the Report

Table 1 : Global Market for Organoids, by Organ Type, Through 2027
Table 2 : Global Market for Intestine Organoids, by Region, Through 2027
Table 3 : Global Market for Liver Organoids, by Region, Through 2027
Table 4 : Global Market for Stomach Organoids, by Region, Through 2027
Table 5 : Global Market for Pancreatic Organoids, by Region, Through 2027
Table 6 : Global Market for Lung Organoids, by Region, Through 2027
Table 7 : Global Market for Kidney Organoids, by Region, Through 2027
Table 8 : Global Market for Other Organoids Segment, by Region, Through 2027
Table 9 : Global Market for Organoids, by Application, Through 2027
Table 10 : Global Market for Organoids in Developmental Biology, by Region, Through 2027
Table 11 : Global Market for Organoids in Drug Discovery and Personalized Medicine, by Region, Through 2027
Table 12 : Global Market for Organoids in Regenerative Medicine, by Region, Through 2027
Table 13 : Global Market for Organoids in Pathology of Infectious Disease, by Region, Through 2027
Table 14 : Global Market for Organoids in Drug Toxicity and Efficacy Testing, by Region, Through 2027
Table 15 : Global Market for Organoids, by Region, Through 2027
Table 16 : North American Market for Organoids, by Organ Type, Through 2027
Table 17 : North American Market for Organoids, by Country, Through 2027
Table 18 : European Market for Organoids, by Organ Type, Through 2027
Table 19 : European Market for Organoids, by Country, Through 2027
Table 20 : Asia-Pacific Market for Organoids, by Organ Type, Through 2027
Table 21 : Asia-Pacific Market for Organoids, by Country, Through 2027
Table 22 : Rest of the World Market for Organoids, by Organ Type, Through 2027
Table 23 : Review of Selected Patents and Patent Applications on Organoids, 2008-2021
Table 24 : Global Number of Transplanted Organs, by Country, 2017
Table 25 : Global Organoids Vendors, by Ranking, 2021
Table 26 : Alpha Genesis Inc.: Recent Developments, 2017-2020
Table 27 : Charles River Laboratories International Inc.: Recent Developments, 2020-2022
Table 28 : Envigo: Types of Laboratory Animals
Table 29 : Envigo: Recent Developments, 2021-2022
Table 30 : GenOway: Recent Developments, 2018-2022
Table 31 : LabCorp Drug Development: Recent Developments, 2022
Table 32 : The Jackson Laboratory: Recent Developments, 2021
Table 33 : Janvier Labs: Segments
Table 34 : Taconic Biosciences: Segments
Table 35 : Transgenic Inc.: Segments
Table 36 : Transgenic Inc.: Company Financials, 2014-2018
Table 37 : Transposagen Biopharmaceuticals Inc.: Segments
Table 38 : Organovo: Expenses on R&D, 2016-2020
Table 39 : Cellesce.: Recent Developments, 2018-2022
Table 40 : Cincinnati Children's Hospital Medical Center: Recent Developments, 2021
Table 41 : Crown Bioscience: Recent Developments, 2021-2022
Table 42 : Corning Inc.: Recent Developments, 2018-2021
Table 43 : DefiniGEN: Recent Developments, 2020-2021
Table 44 : Hubrecht Organoid Technology (HUB): Recent Developments, 2017-2021
Table 45 : Merck KGaA: Products Offered
Table 46 : Merck KGaA: Recent Developments, 2020-2021
Table 47 : STEMCELL Technologies Inc.: Recent Developments, 2018-2022
Table 48 : Thermo Fisher Scientific: Products Offered
Table 49 : Thermo Fisher Scientific: Recent Developments
Table 50 : 3D Biotek LLC: Segments
Table 51 : In Sphero Inc.: Segments
Table 52 : Reprocell Inc.: Acquisitions

List of Figures

Summary Figure : Global Market Share for Organoids, by Organ Type, 2021
Figure 1 : Timeline for Possible Availability of 3D-Printed Organs and Tissues for Humans, 2018-2043
Figure 2 : Timeline for Possible Availability of Organ-on-Chip Devices for Drug Screening in Human Patients, 2018-2030
Figure 3 : Global Market Share for Organoids, by Organ Type, 2021
Figure 4 : Global Market for Intestine Organoids, 2020-2027
Figure 5 : Global Market for Intestine Organoids, by Region, 2020-2027
Figure 6 : Global Market for Liver Organoids, 2020-2027
Figure 7 : Global Market for Liver Organoids, by Region, 2020-2027
Figure 8 : Global Market for Stomach Organoids, 2020-2027
Figure 9 : Global Market for Stomach Organoids, by Region, 2020-2027
Figure 10 : Global Market for Pancreatic Organoids, 2020-2027
Figure 11 : Global Market for Pancreatic Organoids, by Region, 2020-2027
Figure 12 : Global Market for Lung Organoids, 2020-2027
Figure 13 : Global Market for Lung Organoids, by Region, 2020-2027
Figure 14 : Global Market for Kidney Organoids, 2020-2027
Figure 15 : Global Market for Kidney Organoids, by Region, 2020-2027
Figure 16 : Global Market for Other Organoids Segment, 2020-2027
Figure 17 : Global Market for Other Organoids Segment, by Region, 2020-2027
Figure 18 : Global Market Share for Organoids, by Application, 2021
Figure 19 : Global Market for Organoids in Developmental Biology, 2020-2027
Figure 20 : Global Market for Organoids in Developmental Biology, by Region, 2020-2027
Figure 21 : Global Market for Organoids in Drug Discovery and Personalized Medicine, 2020-2027
Figure 22 : Global Market for Organoids in Drug Discovery and Personalized Medicine, by Region, 2020-2027
Figure 23 : Global Market for Organoids in Regenerative Medicine, 2020-2027
Figure 24 : Global Market for Organoids in Regenerative Medicine, by Region, 2020-2027
Figure 25 : Global Market for Organoids in Pathology of Infectious Disease, 2020-2027
Figure 26 : Global Market for Organoids in Pathology of Infectious Disease, by Region, 2020-2027
Figure 27 : Global Market for Organoids in Drug Toxicity and Efficacy Testing, 2020-2027
Figure 28 : Global Market for Organoids in Drug Toxicity and Efficacy Testing, by Region, 2020-2027
Figure 29 : Global Market for Organoids, by Region, 2020-2027
Figure 30 : Global Market Share for Organoids, by Region, 2021
Figure 31 : North American Market Share for Organoids, by Organ Type, 2021
Figure 32 : North American Market Share for Organoids, by Country, 2021
Figure 33 : U.S. Market for Organoids, 2020-2027
Figure 34 : Canadian Market for Organoids, 2020-2027
Figure 35 : European Market Share for Organoids, by Organ Type, 2021
Figure 36 : European Market Share for Organoids, by Country, 2021
Figure 37 : German Market for Organoids, 2020-2027
Figure 38 : French Market for Organoids, 2020-2027
Figure 39 : U.K. Market for Organoids, 2020-2027
Figure 40 : Italian Market for Organoids, 2020-2027
Figure 41 : Spanish Market for Organoids, 2020-2027
Figure 42 : Rest of the European Market for Organoids, 2020-2027
Figure 43 : Asia-Pacific Market Share for Organoids, by Organ Type, 2021
Figure 44 : Asia-Pacific Market Share for Organoids, by Country, 2021
Figure 45 : Chinese Market for Organoids, 2020-2027
Figure 46 : Japanese Market for Organoids, 2020-2027
Figure 47 : Australian Market for Organoids, 2020-2027
Figure 48 : Indian Market for Organoids, 2020-2027
Figure 49 : Rest of Asia-Pacific Market for Organoids, 2020-2027
Figure 50 : Rest of the World Market Share for Organoids, by Organ Type, 2021
Figure 51 : Global Number of Transplanted Organs, by Country, 2017
Figure 52 : Charles River Laboratories International Inc.: Net Revenue, 2017-2021
Figure 53 : Charles River Laboratories International Inc.: Revenue Share, by Business Segment, 2021
Figure 54 : Charles River Laboratories International Inc.: Revenue Share, by Region, 2021
Figure 55 : GenOway: Net Revenue, 2019-2021
Figure 56 : LabCorp Drug Development: Net Revenue, 2017-2021
Figure 57 : LabCorp Drug Development: Revenue Share, by Business Segment, 2021
Figure 58 : LabCorp Drug Development: Revenue Share, by Region, 2021
Figure 59 : The Jackson Laboratory: Net Revenue, 2018-2020
Figure 60 : The Jackson Laboratory: Revenue Share, by Business Segment, 2020
Figure 61 : Corning Inc.: Net Revenue, 2019-2021
Figure 62 : Corning Inc.: Revenue Share, by Business Segment, 2020
Figure 63 : Corning Inc.: Revenue Share, by Region, 2020
Figure 64 : Merck KGaA: Net Revenue, 2017-2021
Figure 65 : Merck KGaA: Revenue Share, by Business Segment, 2020
Figure 66 : Merck KGaA: Revenue Share, by Region, 2020
Figure 67 : Thermo Fisher Scientific: Net Revenue, 2017-2021
Figure 68 : Thermo Fisher Scientific: Revenue Share, by Business Segment, 2020
Figure 69 : Thermo Fisher Scientific: Revenue Share, by Region, 2020